ArticleAmerican journal of respiratory and critical care medicine2017
Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.
Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.
- [Interventions to reduce hospital readmission rates in patients with COPD: a systematic review].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2023Pooled it
- Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2020Pooled it
- Risks for Readmission Among Older Patients With Chronic Obstructive Pulmonary Disease: An Analysis Using Korean National Health Insurance Service - Senior Cohort Data.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2023Article
- Integrating Clinical and Air Quality Data to Improve Prediction of COPD Exacerbations.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2023Article
- Observational
- Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2021Article
- Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.Journal of general internal medicine · 2020Article
- Improving continuity of care of patients with respiratory disease at hospital discharge.Breathe (Sheffield, England) · 2020Article
- Article
- The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015.Annals of the American Thoracic Society · 2020Article
- Predicting and preventing hospital readmission for exacerbations of COPD.ERJ open research · 2020Review
- Care coordination for veterans with COPD: a positive deviance study.The American journal of managed care · 2020Article
- Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers.International journal of chronic obstructive pulmonary disease · 2020Article
- The European COPD audit : Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria.Wiener klinische Wochenschrift · 2019Article
- Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.Current opinion in pulmonary medicine · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 6 institutions in 1 country.
Funding
Abstract
rationaleThe Centers for Medicare and Medicaid Services recently implemented financial penalties to reduce hospital readmissions for select conditions, including chronic obstructive pulmonary disease (COPD). Despite growing pressure to reduce COPD readmissions, it is unclear how COPD readmission rates are related to other measures of quality, which could inform efforts on common organizational factors that affect high-quality care.
objectivesTo examine the association between COPD readmissions and other quality measures.
methodsWe analyzed data from the 2015 Centers for Medicare and Medicaid Services annual files, downloaded from the Hospital Compare website. We included 3,705 hospitals nationwide that had publically reported data on COPD readmissions. We compared COPD readmission rates to other risk-adjusted measures of quality, including readmission and mortality rates for other conditions, and patient reports about care experiences. MEASUREMENTS AND MAIN
resultsThere were modest correlations between COPD readmission rates and readmission rates for other medical conditions, including heart failure (r = 0.39; P < 0.01), acute myocardial infarction (r = 0.30; P < 0.01), pneumonia (r = 0.38; P < 0.01), and stroke (r = 0.29; P < 0.01). In contrast, we found low correlations between COPD readmission rates and readmission rates for surgical conditions, as well as mortality rates for all measured conditions. There were significant correlations between COPD readmission rates and all patient experience measures.
conclusionsThese findings suggest there may be common organizational factors that influence multiple disease-specific outcomes. As pay-for-performance programs focus attention on individual disease outcomes, hospitals may benefit from in-depth assessments of organizational factors that affect multiple aspects of hospital quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.